8th Euro Fed Lipid Congress in Munich, Germany
LOS ANGELES, Dec. 2, 2010 /PRNewswire-FirstCall/ – Cavitation Technologies Inc, (CTi) (OTC Bulletin Board: CVAT, Frankfurt, Berlin & Stuttgart: WTC).
The 8th Euro Fed Lipid Congress was held in Munich, Germany from November 21 – 24, 2010. http://www.eurofedlipid.org/meetings/munich/. The European Federation for the Science and Technology of Lipids congresses are recognized as annual “don’t miss this!” event of the Lipids, Fats and Oils world with up to 850 delegates, including 200 students. N.V. Desmet Ballestra Group s.a., www.desmetballestra.com , a European based conglomerate and worldwide leader in the design and delivery of advanced processing systems for vegetable (edible) oil extraction and refining facilities throughout the world, was participating at this important Congress. Last month, Desmet and CTi entered into an exclusive new global technology license, marketing and collaboration agreement with respect to CTi’s proprietary Nano Reactor(TM) technology.
According to Roman Gordon, CTi’s CEO, “We are very pleased that Desmet participated at this year’s Euro Fed Lipid Congress in Munich, Germany, as Wim De Greyt and Marc Kellens presented the Nano Neutralization(TM) process to an international audience.” It was an excellent opportunity for us to introduce and promote our unique Nano Neutralization(TM) process. Mr. Gordon also stated that efficiency, quality and sustainability are key criteria for our new improved process in edible oil refining.
CTi is a technology research and development company engaged primarily in the development of environmentally clean Nano Reactor(TM) technologies and liquids processing applications and solutions in various fields and industries, including natural plant (vegetable) oil processing and refining; renewable fuels; petroleum refining and petrochemicals; water and wastewater treatment; and the food and beverage industries. For additional information please visit: www.ctinanotech.com.
This press release contains forward-looking statements, including without limitation those about the Company’s business, plans and strategies. These statements involve risks and uncertainties, and actual results may differ. Risks and uncertainties include without limitation the effect of business, economic and competitive market conditions; business decisions by suppliers, licensees and customers with respect to the Company’s technologies and products; the ability of the Company to develop new or additional innovative technologies, applications and processes in various fields and industries, and to stimulate customer demand for its technologies and products; the size and growth of markets for the Company’s technologies and products; the Company’s ability to implement licensing and marketing strategies, including execution of revenue generation plans and models; the continued availability of essential components and services that are currently obtained from sole or limited sources; the Company’ ability to protect its intellectual property in international markets; the success of patent licensing and marketing strategies and objectives; the success of business relationships with licensees, partners, suppliers and customers; the timing and successful completion of research & development projects, whether existing or new patent applications will be granted, and the potential for infringement of the Company’s intellectual property by others; the timely completion of acquisitions; the ability of the Company to fund its capital requirements; and its ability to attract and retain key personnel.
Additional information on potential factors that could affect the Company’s performance or financial results is included from time to time in the Company’s public reports filed with the SEC. The Company assumes no obligation to revise or update any forward-looking statements or information, which are effective or apply only as of their respective dates of publication.
References to CTi, the CTi logo, Nano Reactor System, Nano Reactors, Nano Neutralization and other terms that describe the Company’s technologies, applications, processes and products are trademarks of the Company. Other company and product names may be trademarks of their respective owners.